Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Jul-19 8:02 PM View:  | Cox Carrie Smith Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 18,000 | $21.33 | $384,000.00 | (100%) 18.0K to 0 | |
| 30-Jul-19 8:04 PM View: | Orwin John A Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 20,000 | $36.00 | $720,000.00 | (100%) 20.0K to 0 | |
| 30-Jul-19 8:03 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 5,085 | $0.80 | $4,080.00 | (3%) 202.72K to 197.63K | |
| 30-Jul-19 8:06 PM View: | Squarer Ron CEO Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 702,081 | $17.77 | $12,474,800.00 | (100%) 702.08K to 0 | |
| 30-Jul-19 8:05 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 324,364 | $31.01 | $10,058,100.00 | (100%) 324.36K to 0 | 5% |
| 30-Jul-19 8:02 PM View: | Baum Charles M Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition (change in control) | 15,000 | $48.00 | $720,000.00 | (100%) 15.0K to 0 | |
| 30-Jul-19 8:03 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition (change in control) | 35,000 | $48.00 | $1,680,000.00 | (24%) 145.0K to 110.0K | |
| 30-Jul-19 8:03 PM View: | Haddock Jason CFO | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 86,085 | $16.76 | $1,442,830.00 | (100%) 86.08K to 0 | |
| 30-Jul-19 8:03 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 30,000 | $48.00 | $1,440,000.00 | (15%) 197.63K to 167.63K | |
| 30-Jul-19 8:04 PM View: | Robbins Andrews R COO | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 201,564 | $16.91 | $3,409,060.00 | (100%) 201.56K to 0 | |
| 30-Jul-19 8:03 PM View: | Fyfe Gwen A. Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 20,000 | $36.00 | $720,000.00 | (100%) 20.0K to 0 | |
| 30-Jul-19 8:05 PM View: | Sharp Shalini Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 10,000 | $24.00 | $240,000.00 | (100%) 10.0K to 0 | |
| 30-Jul-19 8:06 PM View: | van Lunsen Gil J Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 29,297 | $39.81 | $1,166,260.00 | (100%) 29.3K to 0 | |
| 30-Jul-19 8:02 PM View: | Baum Charles M Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 5,000 | -- | -- | (25%) 20.0K to 15.0K | |
| 30-Jul-19 8:04 PM View: | Saccomano Nicholas A CSO | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition | 212,003 | $34.00 | $7,209,120.00 | (100%) 212.0K to 0 | |
| 30-Jul-19 8:03 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 30-Jul-19 | Disposition (change in control) | 22,635 | $48.00 | $1,086,480.00 | (14%) 167.63K to 145.0K | |
| 06-Jun-19 4:02 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 04-Jun-19 | Option Exercise | 100,000 | $7.30 | $730,000.00 | 48% 209.54K to 309.54K | |
| 06-Jun-19 4:02 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 04-Jun-19 | Market Option Sale (Planned) | 100,000 | $28.51 | $2,851,000.00 | (32%) 309.54K to 209.54K | |
| 03-Jun-19 4:03 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 03-Jun-19 | Option Exercise | 36,134 | $3.65 | $131,889.00 | 17% 209.54K to 245.68K | |
| 03-Jun-19 4:03 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 03-Jun-19 | Market Option Sale (Planned) | 36,134 | $27.58 | $996,738.00 | (15%) 245.68K to 209.54K | (2%) |
| 03-Jun-19 4:03 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 30-May-19 | Option Exercise | 15,728 | $3.65 | $57,407.20 | 8% 209.54K to 225.27K | |
| 03-Jun-19 4:03 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 30-May-19 | Market Option Sale (Planned) | 15,728 | $27.50 | $432,520.00 | (7%) 225.27K to 209.54K | (2%) |
| 28-May-19 4:04 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 28-May-19 | Market Option Sale (Planned) | 46,766 | $27.00 | $1,262,820.00 | (16%) 284.46K to 237.69K | (4%) |
| 28-May-19 4:04 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 28-May-19 | Option Exercise | 46,766 | $3.65 | $170,696.00 | 20% 237.69K to 284.46K | |
| 28-May-19 4:04 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 28-May-19 | Market Sale (Planned) | 28,149 | $27.00 | $760,107.00 | (12%) 237.69K to 209.54K | (4%) |
| 28-May-19 4:04 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 23-May-19 | Option Exercise | 40,634 | $3.65 | $148,314.00 | 17% 237.69K to 278.33K | |
| 28-May-19 4:04 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 23-May-19 | Market Option Sale (Planned) | 40,634 | $26.50 | $1,076,850.00 | (15%) 278.33K to 237.69K | (6%) |
| 23-May-19 5:26 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 21-May-19 | Market Option Sale (Planned) | 12,600 | $26.50 | $333,900.00 | (5%) 250.29K to 237.69K | (6%) |
| 23-May-19 5:26 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 21-May-19 | Option Exercise | 12,600 | $3.65 | $45,990.00 | 5% 237.69K to 250.29K | |
| 03-Apr-19 4:30 PM View: | Saccomano Nicholas A CSO | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Payment of Exercise | 6,048 | $24.60 | $148,781.00 | (4%) 156.24K to 150.19K | (14%) |
| 03-Apr-19 4:31 PM View: | Squarer Ron CEO Director | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Option Exercise | 37,813 | -- | -- | 16% 238.71K to 276.52K | |
| 03-Apr-19 4:30 PM View: | Saccomano Nicholas A CSO | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Option Exercise | 13,750 | -- | -- | 10% 142.49K to 156.24K | |
| 03-Apr-19 4:30 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Payment of Exercise | 6,932 | $24.60 | $170,527.00 | (3%) 244.62K to 237.69K | (14%) |
| 03-Apr-19 4:30 PM View: | Sandor Victor Chief Medical Officer | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Option Exercise | 15,626 | -- | -- | 7% 229.0K to 244.62K | |
| 03-Apr-19 4:31 PM View: | Robbins Andrews R COO | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Option Exercise | 19,688 | -- | -- | 33% 59.99K to 79.68K | |
| 03-Apr-19 4:31 PM View: | Squarer Ron CEO Director | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Payment of Exercise | 16,631 | $24.60 | $409,123.00 | (6%) 276.52K to 259.89K | (14%) |
| 03-Apr-19 4:31 PM View: | Robbins Andrews R COO | Array BioPharma, Inc. (ARRY) | 01-Apr-19 | Payment of Exercise | 8,660 | $24.60 | $213,036.00 | (11%) 79.68K to 71.02K | (14%) |
| 21-Feb-19 4:30 PM View: | Cox Carrie Smith Director | Array BioPharma, Inc. (ARRY) | 19-Feb-19 | Market Purchase | 5,000 | $23.20 | $115,998.00 | 167% 3.0K to 8.0K | 21% |
| 08-Feb-19 6:34 PM View: | Haddock Jason CFO | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Option Exercise | 85,000 | $3.77 | $320,450.00 | 283% 30.06K to 115.06K | |
| 08-Feb-19 6:34 PM View: | Haddock Jason CFO | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Market Sale (Planned) | 11,712 | $22.05 | $258,257.00 | (28%) 41.77K to 30.06K | (28%) |
| 08-Feb-19 6:31 PM View: | Squarer Ron CEO Director | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Market Option Sale (Planned) | 110,000 | $21.64 | $2,380,020.00 | (32%) 348.71K to 238.71K | (30%) |
| 08-Feb-19 6:32 PM View: | Saccomano Nicholas A CSO | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Market Option Sale (Planned) | 187,264 | $21.58 | $4,041,760.00 | (57%) 329.75K to 142.49K | (30%) |
| 08-Feb-19 6:31 PM View: | Squarer Ron CEO Director | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Option Exercise | 110,000 | $3.61 | $397,100.00 | 46% 238.71K to 348.71K | |
| 08-Feb-19 6:32 PM View: | Saccomano Nicholas A CSO | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Option Exercise | 187,264 | $3.67 | $687,509.00 | 131% 142.49K to 329.75K | |
| 08-Feb-19 6:34 PM View: | Haddock Jason CFO | Array BioPharma, Inc. (ARRY) | 07-Feb-19 | Market Option Sale (Planned) | 73,288 | $22.05 | $1,616,040.00 | (64%) 115.06K to 41.77K | (28%) |
| 08-Feb-19 6:36 PM View: | Robbins Andrews R COO | Array BioPharma, Inc. (ARRY) | 06-Feb-19 | Market Sale | 114,626 | $20.02 | $2,295,390.00 | (66%) 174.62K to 59.99K | (40%) |
| 08-Feb-19 7:14 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 06-Feb-19 | Option Exercise | 25,000 | $10.47 | $261,750.00 | 37% 67.72K to 92.72K | |
| 08-Feb-19 7:14 PM View: | Lefkoff Kyle Director | Array BioPharma, Inc. (ARRY) | 06-Feb-19 | Market Option Sale | 25,000 | $20.51 | $512,692.00 | (27%) 92.72K to 67.72K | (37%) |
| 08-Feb-19 6:36 PM View: | Robbins Andrews R COO | Array BioPharma, Inc. (ARRY) | 06-Feb-19 | Option Exercise | 125,000 | $5.70 | $712,625.00 | 72% 174.62K to 299.62K | |
| 08-Feb-19 6:34 PM View: | Haddock Jason CFO | Array BioPharma, Inc. (ARRY) | 06-Feb-19 | Market Option Sale (Planned) | 11,712 | $20.00 | $234,240.00 | (28%) 41.77K to 30.06K | (41%) |
